First Wave To Merge With ImmunogenX With Focus On Celiac Disease

 
• By Joseph Haas
  
Gluten-free
First Wave merges with ImmunogenX with a goal of producing the first celiac disease drug • Source: Shutterstock

More from Deals

More from Business